TCO-PEG3-Maleimide>90.0%(HPLC)5mg

(2S,3S,4R,5R,6R)-2-(3-(4-Acetoxybenzyl)-4-chlorophenyl)-6-(acetoxymethyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate, 98%, 10mg

5-(4-Pyridyl)-1,3,4-thiadiazol-2-yl-amine, 99.0%, 10g

EMPAGLIFLOZIN, 95%, 25g

3,7-Diethylnonane-4,6-dione, 97.0%, 5g

Dichlorodimethylsilane>98.0%(GC)500mL

7-Chloroquinoline>98.0%(GC)5g

(S)-1-[4-(Trifluoromethyl)phenyl]ethylamine hydrochloride, 95.0%, 100mg

tert-Butyl 5-bromo-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95.0%, 5g

Cis-1-(tert-butoxycarbonyl)-4-fluoropyrrolidine-3-carboxylic acid, 95.0%, 50mg

[(4-tert-butylphenyl)methyl](prop-2-en-1-yl)amine, 95.0%, 2g

2,4-Dichloro-5-(chloromethyl)pyridine, 95.0%, 1g

Tetrahydrofuran, min. 99.5%, for synthesis, 250 ml, glass packaging